 |
|
In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins
Shubhashish Chakraborty, Reshita Baruah, Neha Mishra, Ashok K Varma
Genomics Inform. 2023;21(3):e30 Published online 2023 Sep 27 DOI: https://doi.org/10.5808/gi.22069
|
|
Citations to this article as recorded by
 Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study
Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone
Molecules.2024; 29(5): 1024. CrossRef Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian-Bogdan Tigu, Raluca Munteanu, Cristian-Silviu Moldovan, David Kegyes, Anca Onaciu, Diana Gulei, Gabriel Ghiaur, Hermann Einsele, Carlo M. Croce
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef
|